Professional Seasonal Analysis for Trading

Royalty Pharma plc - Class A Ordinary Shares (RPRX)

Seasonality Analysis

Stocks 6 Years Analyzed

Royalty Pharma plc - Class A Ordinary Shares Annual Seasonality Statistics

2.75%
Avg Annual Return
54.4%
Avg Monthly Win Rate
6/12
Positive Months
6
Years Analyzed

Royalty Pharma plc - Class A Ordinary Shares Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January BEST 5.30%
83%
Very Strong
February 1.81%
50%
Weak
March -2.19%
67%
Weak
April 1.15%
67%
Moderate
May -3.96%
20%
Very Weak
June 2.24%
67%
Strong
July -0.47%
67%
Weak
August -1.54%
33%
Very Weak
September WORST -4.18%
17%
Very Weak
October -0.12%
67%
Weak
November 3.78%
67%
Strong
December 0.93%
50%
Weak

Royalty Pharma plc - Class A Ordinary Shares 2026 vs Historical Pattern

Current Position
99.1
Historical Avg Position
55.28
Deviation
+43.82
Performance
Significantly Above Average

Royalty Pharma plc - Class A Ordinary Shares Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for RPRX with overlay patterns, custom date ranges, and more.

Create Free Account

Royalty Pharma plc - Class A Ordinary Shares Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Royalty Pharma plc - Class A Ordinary Shares Seasonal Historical Performance

Historical Performance

See historical average returns for RPRX across multiple timeframes.

Create Free Account

About Royalty Pharma plc - Class A Ordinary Shares (RPRX) Seasonality

Royalty Pharma plc - Class A Ordinary Shares (RPRX) has been analyzed using 6 years of historical data to identify seasonal patterns. Classified under Stocks, Royalty Pharma plc - Class A Ordinary Shares shows distinct seasonal tendencies based on historical data.

The strongest month for Royalty Pharma plc - Class A Ordinary Shares is historically January, with an average return of 5.30% and a win rate of 83%. Conversely, September tends to be the weakest month, averaging -4.18% return.

Looking at the full calendar year, Royalty Pharma plc - Class A Ordinary Shares has an average annual return of 2.75% with an overall monthly win rate of 54.4%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Royalty Pharma plc - Class A Ordinary Shares has a consistency score of 51 (Fair), based on 7 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Royalty Pharma plc - Class A Ordinary Shares Seasonality FAQ

What is the best month to buy Royalty Pharma plc - Class A Ordinary Shares (RPRX)?

Historically, January has been the best month for Royalty Pharma plc - Class A Ordinary Shares, with an average return of 5.30% and a win rate of 83%. However, past performance does not guarantee future results.

What is the worst month for Royalty Pharma plc - Class A Ordinary Shares (RPRX)?

Based on historical data, September has been the weakest month for Royalty Pharma plc - Class A Ordinary Shares, with an average return of -4.18%. This is a historical observation and does not guarantee future results.

How reliable is RPRX seasonality data?

The seasonality analysis for Royalty Pharma plc - Class A Ordinary Shares is based on 6 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Royalty Pharma plc - Class A Ordinary Shares seasonality in my trading?

Use Royalty Pharma plc - Class A Ordinary Shares (RPRX) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.